AU5135396A - Biosynthetic virus vectors for gene therapy - Google Patents
Biosynthetic virus vectors for gene therapyInfo
- Publication number
- AU5135396A AU5135396A AU51353/96A AU5135396A AU5135396A AU 5135396 A AU5135396 A AU 5135396A AU 51353/96 A AU51353/96 A AU 51353/96A AU 5135396 A AU5135396 A AU 5135396A AU 5135396 A AU5135396 A AU 5135396A
- Authority
- AU
- Australia
- Prior art keywords
- biosynthetic
- gene therapy
- virus vectors
- virus
- vectors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/10041—Use of virus, viral particle or viral elements as a vector
- C12N2740/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39535595A | 1995-02-28 | 1995-02-28 | |
US395355 | 1995-02-28 | ||
PCT/US1996/002877 WO1996026745A1 (en) | 1995-02-28 | 1996-02-28 | Biosynthetic virus vectors for gene therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5135396A true AU5135396A (en) | 1996-09-18 |
Family
ID=23562692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU51353/96A Abandoned AU5135396A (en) | 1995-02-28 | 1996-02-28 | Biosynthetic virus vectors for gene therapy |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0824362A1 (en) |
AU (1) | AU5135396A (en) |
WO (1) | WO1996026745A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020048598A1 (en) * | 1997-06-13 | 2002-04-25 | Navid Malik | Internally supported lipid vesicle systems |
DE69838584T2 (en) | 1997-08-04 | 2008-06-26 | Cell Genesys, Inc., Foster City | ENHANCERS OF HUMAN GLANDULAR CALLIQUE, VECTORS CONTAINING HIM, AND METHODS FOR ITS USE |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4897355A (en) * | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
EP0646178A1 (en) * | 1992-06-04 | 1995-04-05 | The Regents Of The University Of California | expression cassette with regularoty regions functional in the mammmlian host |
EP0652775B1 (en) * | 1992-07-27 | 2000-04-19 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Targeting of liposomes to the blood-brain barrier |
US5334761A (en) * | 1992-08-28 | 1994-08-02 | Life Technologies, Inc. | Cationic lipids |
US5470955A (en) * | 1993-02-02 | 1995-11-28 | Dartmouth College | Antibodies which specifically bind mcl-1 polypeptide |
-
1996
- 1996-02-28 AU AU51353/96A patent/AU5135396A/en not_active Abandoned
- 1996-02-28 EP EP96907918A patent/EP0824362A1/en not_active Withdrawn
- 1996-02-28 WO PCT/US1996/002877 patent/WO1996026745A1/en active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
EP0824362A1 (en) | 1998-02-25 |
WO1996026745A1 (en) | 1996-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2552795A (en) | Safe vectors for gene therapy | |
AU699706C (en) | Improved vectors for gene therapy | |
AU5153296A (en) | Vectors for gene delivery | |
AU5638496A (en) | Viral vectors | |
AU5723696A (en) | Gene therapy using replication competent targeted adenoviral vectors | |
AU5671696A (en) | Scytalidium catalase gene | |
AU6011496A (en) | Improved pharmaceutical compositions for gene therapy | |
AU4787697A (en) | Therapeutic gene | |
AU5586398A (en) | Submersive therapy apparatus | |
AU7019494A (en) | Genetic therapy for cardiovascular disease | |
AU5268696A (en) | Novel compounds and methods for therapy | |
AU5316096A (en) | Gene therapy by secretory gland expression | |
AU690034B2 (en) | Sequence controller | |
AU6535096A (en) | Methods and means for targeted gene delivery | |
AU3737297A (en) | Bacteriophage-mediated gene therapy | |
AU3169495A (en) | Gene therapy for restenosis using an adenoviral vector | |
AU6489996A (en) | Methods for increasing protein expression | |
AU4954496A (en) | Gene transfer preparation | |
AU2721997A (en) | Design of novel highly efficient hiv based packaging systems for gene therapy | |
IL117713A0 (en) | Gene expression system | |
AU5315796A (en) | Mammalian expression vectors | |
AU4401297A (en) | Improved retroviral vectors for gene therapy | |
AU4425397A (en) | Antisense gene therapy for rna viruses | |
AU6254799A (en) | Anti-ige gene therapy | |
AU4941096A (en) | Self-deleting vectors for gene therapy |